Connecticut 2013 Regular Session

Connecticut House Bill HB05347 Compare Versions

OldNewDifferences
11 General Assembly Committee Bill No. 5347
22 January Session, 2013 LCO No. 4037
3- *_____HB05347GL____031413____*
3+ *04037HB05347GL_*
44 Referred to Committee on GENERAL LAW
55 Introduced by:
66 (GL)
77
88 General Assembly
99
1010 Committee Bill No. 5347
1111
1212 January Session, 2013
1313
1414 LCO No. 4037
1515
16-*_____HB05347GL____031413____*
16+*04037HB05347GL_*
1717
1818 Referred to Committee on GENERAL LAW
1919
2020 Introduced by:
2121
2222 (GL)
2323
2424 AN ACT CONCERNING PRESCRIPTION DRUG LABELS.
2525
2626 Be it enacted by the Senate and House of Representatives in General Assembly convened:
2727
2828 Section 1. Section 20-617 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2014):
2929
3030 (a) Each pharmacist shall include on the label of each prescription container: (1) The quantity of prescribed drug placed in such container, in addition to any other information required by law; and (2) a prominently printed expiration date based on the manufacturer's recommended conditions of use and storage that can be read and understood by the ordinary individual. The expiration date required pursuant to subdivision (2) of this section shall be no later than the expiration date determined by the manufacturer.
3131
3232 (b) If a nonbrand name drug is dispensed, each pharmacist shall include the name of the brand name and name of the generic drug on the label of the prescription container. The information required pursuant to this subsection shall be in the following form, with the generic name and brand name inserted as appropriate: "_____ Generic for _____."
3333
3434
3535
3636
3737 This act shall take effect as follows and shall amend the following sections:
3838 Section 1 January 1, 2014 20-617
3939
4040 This act shall take effect as follows and shall amend the following sections:
4141
4242 Section 1
4343
4444 January 1, 2014
4545
4646 20-617
4747
48+Statement of Purpose:
49+
50+To lower the incidence of drug overdoses.
51+
52+[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]
4853
4954
50-GL Joint Favorable
5155
52-GL
56+Co-Sponsors: REP. HURLBURT, 53rd Dist.
5357
54-Joint Favorable
58+Co-Sponsors:
59+
60+REP. HURLBURT, 53rd Dist.
61+
62+H.B. 5347